Mai O. Kadry | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry,National Research Center, Egypt

Dr. Mai Osman Mohamed Kadry is a distinguished biochemistry researcher at the Therapeutic Chemistry Department, National Research Centre, Egypt. With a Doctorate in Biochemistry from Cairo University (2016), her work focuses on oxidative injury, nanotoxicity, and cancer therapy. She has published extensively in high-impact journals on topics like antioxidant effects, stem cell therapies, and metabolic disorders. Dr. Kadry has also contributed to academia, teaching pharmacognosy at 6th October University. Skilled in advanced techniques like PCR, HPLC, and ELISA, she actively participates in groundbreaking nanobiotechnology research projects. Dr. Kadry is committed to advancing therapeutic strategies for critical diseases. πŸ“šπŸ§¬

Publication Profile

Scopus

Academic and Professional Experience πŸŒŸπŸŽ“

Assist. Prof. Dr. Mai O. Kadry has accumulated valuable experience in academia and research. She served as a pharmacognosy instructor at the Faculty of Pharmacy, 6th October University, Cairo, Egypt (2003–2004), where she effectively delivered courses on natural products and their therapeutic applications. Dr. Kadry also contributed as a staff member focused on development and quality enhancement, aligning with the standards of the National Commission for Academic Accreditation. Her dedication to education and quality assurance reflects her commitment to fostering academic excellence and professional growth in pharmaceutical sciences. πŸ“šπŸ”¬

 

Educational Background πŸŽ“πŸ“˜

Assist. Prof. Dr. Mai O. Kadry boasts a strong academic foundation in pharmaceutical sciences. She earned her Doctorate in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a thesis on the “Amelioration of Nano-Sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She obtained her Master’s degree in Pharmaceutical Sciences from Helwan University in 2008, focusing on the synergistic effects of phytic and catechin on carbon tetrachloride-induced damage in rats. Dr. Kadry completed her B.Sc. in Pharmaceutical Science at Ain Shams University in 2003, graduating with honors. She also attended English language schools, enhancing her global communication skills. πŸŒŸπŸ”¬

 

Training πŸ§¬πŸ“š

Assist. Prof. Dr. Mai O. Kadry has undergone extensive training in various scientific disciplines. She completed courses in Biostatistics (November 2016) and Bioinformatics (January 2017) at the National Research Centre. Earlier, she gained expertise in Scientific Typewriting Bases (March 2007) and Occupational Health and Safety (June 2009). Additionally, she mastered Protein Electrophoresis through a four-month course in 2006. Dr. Kadry enhanced her practical skills with hands-on training at Al-Borg Clinical Laboratory, focusing on PCR techniques for detecting HBV and HCV at the Theodor Bilharz Research Institute. Her comprehensive training equips her with valuable laboratory and analytical skills. πŸ”¬πŸ§ͺ

 

Research Focus πŸ§ͺ🧠🧬

Assist. Prof. Dr. Mai O. Kadry focuses on cutting-edge biomedical research, emphasizing toxicity, cancer therapy, and molecular biology. Her work explores inflammatory mediators, DNA damage, and therapeutic approaches in liver, brain, and nephrotoxicity contexts. She investigates autophagy, necroptosis, and novel strategies like resveratrol nano-formulations for ovarian cancer. Dr. Kadry also studies molecular pathways in gastric and prostate cancers, including miRNA-lncRNA signaling and CRISPR-Cas9 applications. Other interests involve genetic mutations in leukemia, drug-delivery systems, and nanotechnology for breast cancer. Her contributions bridge diagnostics, therapeutic innovations, and cellular mechanisms in oncology and toxicology. πŸ”¬βœ¨

 

Publication Top Notes

  • Inflammatory mediators-induced DNA damage in liver and brain injury: Therapeutic approach of 5-Methoy-N-acetyltryptamine – 2024, Toxicology Reports 🧬
  • Necroptosis and autophagy in cisplatinum-triggered nephrotoxicity: Novel insights regarding prognostic and diagnostic potential – 2024, Toxicology Reports πŸ§ͺ
  • Resveratrol-based nano-formulations as a therapeutic strategy for ovarian carcinoma: Autophagy and SIRT-1 signaling – 2024, Cancer Nanotechnology πŸ’Š
  • miR-122-IGF-1R signaling allied with dysregulated lncRNA MALAT-1 in gastric carcinoma – 2024, Toxicology Reports πŸ”¬ (Cited by: 1)
  • Reciprocal crosslink among MeCP2/BDNF/CREB signaling in autism spectrum disorder – 2024, Toxicology Reports 🧠
  • CRISPR-Cas9 genome and lncRNAs for prostate cancer therapy via liposomal compounds – 2024, PLoS ONE 🧬 (Cited by: 1)
  • Collaboration of Hprt/K-RAS/c-Myc mutation in T-lymphocytic leukemia oncogenesis – 2024, Future Science OA πŸ§ͺ (Cited by: 1)
  • Thioctic acid shield against lipopolysaccharide depression and endoplasmic stress – 2024, Future Science OA 🧫
  • Titanium dioxide nanostructure-loaded Adriamycin in breast cancer therapy – 2024, Future Science OA πŸŽ—οΈ (Cited by: 1)
  • Alleviation of doxorubicin adverse effects via drug-delivery systems – 2024, Therapeutic Delivery πŸš‘

 

mojtaba Mortazavi | Genetics and Molecular Biology | Best Researcher Award

mojtaba Mortazavi | Genetics and Molecular Biology | Best Researcher Award

Dr mojtaba Mortazavi, kerman university, Iran

Dr. Mojtaba Mortazavi, a distinguished biochemist, earned his B.S. in Biology (2000) and Ph.D. in Biochemistry (2011) from Tarbiat Modares University, Tehran, Iran. His research spans enzyme structure-function relationships, protein engineering, molecular docking, antimicrobial peptides, and biosensors. Dr. Mortazavi has contributed to notable projects, including stabilizing luciferase enzymes and screening Ξ²-lactamase-producing bacteria. He is a prolific author, with publications inΒ Protein Engineering, Design & SelectionΒ andΒ Current Pharmaceutical Biotechnology.Β His work on drought-responsive proteins and enzyme kinetics is widely recognized. Passionate about innovation, Dr. Mortazavi explores bioluminescence, bioinformatics, and pharmaceutical biotechnology. πŸŒŸπŸ“š

Publication Profile

google scholar

Education

Dr. Mojtaba Mortazavi embarked on his academic journey with a High School Diploma from 12 Bahman High School, Jannat Shahr, Darab, Iran, in 1996 πŸŽ“. He earned his B.S. in Biology from Shahid Chamran University, Ahvaz, Iran, in 2000 πŸ§ͺ. Pursuing his passion for biochemistry, he completed his M.Sc. in Biochemistry at the College of Biological Sciences, Tarbiat Modares University, Tehran, Iran, in 2006 🧫. Dr. Mortazavi culminated his academic achievements with a Ph.D. in Biochemistry from the same university in 2011, specializing in advanced biochemical research and applications πŸ₯ΌπŸ”¬.

Experience

Dr. Mojtaba Mortazavi is a leading expert in enzyme structure-function relationships and pharmaceutical biotechnology. His work spans molecular identification of β-lactamase-producing bacteria, antimicrobial peptides, and protein-protein interactions. Skilled in recombinant enzyme production, he applies advanced techniques like circular dichroism, fluorescence spectroscopy, and bioinformatics for structural characterization and molecular docking. Dr. Mortazavi excels in peptide engineering, cell culture, and biosensor development, alongside pioneering bioluminescence applications and drought-responsive protein identification in tea. With expertise in cloning, expression, and purification of enzymes, his research bridges biotechnology and pharmaceutical innovation, fostering advancements in nano alumina evaluations and rare codon analysis. 🌱✨

Research Projects

Dr. Mojtaba Mortazavi has contributed significantly to various groundbreaking research areas. His work includes theΒ cloning and characterization of firefly luciferaseΒ from a new lampyroid species πŸ”₯, exploringΒ extended-spectrum Ξ²-lactamase-producing bacteriaΒ from clinical specimens 🦠, and theΒ stabilization of luciferase enzymeΒ using site-directed mutagenesis 🧬. Additionally, Dr. Mortazavi led theΒ internal evaluation of the Research Department of BiotechnologyΒ at the Institute of Science and High Technology and Environmental Sciences 🏫. These studies reflect his commitment to advancing biotechnology and microbial research.

Research Focus

Dr. Mojtaba Mortazavi’s research spans multiple domains, primarily focusing onΒ protein engineering,Β biocatalysis, andΒ biochemical analysis. His work includes the design ofΒ thermostable luciferases,Β catalytic nanocomposites, and studies on theΒ Pichia pastoris expression systemΒ for protein production. He also investigates the effects ofΒ ionic liquidsΒ on enzyme structure and activity. His interdisciplinary approach also touches onΒ biotechnology,Β molecular dynamics, andΒ drug design. Key areas of his expertise includeΒ biocatalysis,Β nanocomposites,Β biochemical systems, andΒ enzymology. πŸ§¬πŸ”¬βš™οΈπŸŒ±

Publication top Notes

Design of thermostable luciferases through arginine saturation in solvent-exposed loops

New developments in Pichia pastoris expression system, review and update

Synthesis and characterization of GO/ZIF-67 nanocomposite: investigation of catalytic activity for the determination of epinine in the presence of dobutamine

The effect of different percentages of triethanolammonium butyrate ionic liquid on the structure and activity of urate oxidase: Molecular docking, molecular dynamics simulation …

cDNA cloning, expression and homology modeling of a luciferase from the firefly Lampyroidea maculata

Design, synthesis and biological assessment of acridine derivatives containing 1, 3, 4-thiadiazole moiety as novel selective acetylcholinesterase inhibitors

Evaluation of tea (Camellia sinensisΒ L.) biochemical traits in normal and drought stress conditions to identify drought tolerant clones

Spectroscopic and functional characterization ofΒ Lampyris turkestanicusΒ luciferase: a comparative study

Enhancement of Thermostability ofΒ Aspergillus flavusΒ Urate Oxidase by Immobilization on the Ni-Based Magnetic Metal–Organic Framework

Surface charge modification increases firefly luciferase rigidity without alteration in bioluminescence spectra

Effects of 940 MHz EMF on luciferase solution: Structure, function, and dielectric studies